Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.
about
Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A ReviewIdentifying prognostic features by bottom-up approach and correlating to drug repositioningToward better soft tissue sarcoma staging: building on american joint committee on cancer staging systems versions 6 and 7.Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Endoscopic full-thickness resection and laparoscopic surgery for treatment of gastric stromal tumors.The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasmsIdentification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumorsMED12 alterations in both human benign and malignant uterine soft tissue tumors.Response to chemotherapy is not related to chromosome instability in synovial sarcoma.Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.PDL1 expression is an independent prognostic factor in localized GIST.Endoscopic therapy for gastric stromal tumors originating from the muscularis propria.Genomic Grade Index predicts postoperative clinical outcome of GIST.Genomic mapping of pathways in endometrial adenocarcinoma and a gastrointestinal stromal tumor located in Meckel's diverticulumGene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells.Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.Multi-layered cancer chromosomal instability phenotype.Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.Heterogeneity in sarcoma cell lines reveals enhanced motility of tetraploid versus diploid cells.The cancer biology of whole-chromosome instability.Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort.Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors.RhoB promotes γH2AX dephosphorylation and DNA double-strand break repairFrequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors.[Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].Emerging drugs for the treatment of gastrointestinal stromal tumour.New targets and therapies for gastrointestinal stromal tumors.Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.Latest advances in adult gastrointestinal stromal tumors.Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation ofSPP1as an independent prognostic factor
P2860
Q26783412-3F6BD70D-E512-429C-910A-FE19AEF4D206Q28543844-8D1F255D-13CE-4C75-9FB0-5E4172BD6804Q33794219-DF6F96FC-648F-4174-AA12-988A101900EFQ33796945-28717519-2E54-4DEC-B9AE-1CA1D1D0D70FQ33845604-FDCB3FD9-F8DB-419B-B8F3-970F27273FE4Q33905783-C78C5A35-B7F8-4675-B2E1-E66A4C80FDA9Q34100865-A188A42D-6EAC-4D1A-9A85-1B67CA451512Q34328530-224A0E27-57A7-4B62-B981-2171686B4182Q34395325-07EC3778-8008-4874-83F5-60DFAC30BE3DQ35562510-DC91EC95-3FF7-429F-9E40-30479017432DQ35798839-304EFE51-3D46-4371-9E3D-1B593AA54AA4Q36093391-E78E8AB5-F8E7-412A-8991-975975062CA3Q36387916-6CF46F7A-013C-48F1-AB59-8D04F30FDF2EQ36524629-127B5EB7-DE4D-44EC-A30E-1B33F26CA586Q36577759-90C25C21-86C9-4789-9EFE-DF8713123866Q36589296-B823A82A-B3F7-4B93-A9D3-873FF1DFADE3Q37078688-4ACC89C0-8B07-4C80-9C3B-C1EEAA9D69A4Q37350792-DA6EE125-E1B1-477D-BBE5-C7822CFB4054Q37382209-9D611DC4-2E2A-41FD-96B8-7BC1204FC8D2Q37705793-854C119E-6FFD-43F4-ABB1-6DCD2C923C9BQ37725499-215910EA-F7FA-4855-8780-07792C325335Q38074016-4210DA1C-E016-431E-A6E1-F7743A182D1FQ38756648-C666EC93-7DE3-4A67-94E2-575E9BBF053CQ38823874-6D37DE71-0490-494B-9101-986A457C130CQ38986550-359243B1-403F-42D0-BFDB-7A530B7E923AQ39003171-395DBF86-C714-4BB1-B65B-C9EA09F352A8Q39278610-14A5FAE7-D718-4361-9E76-7BD5D292CC0AQ39288497-ACF79066-F205-4035-A9A0-B488B2869717Q40988035-92400A7A-B7C4-44F6-8DEB-86D33BCA9F5AQ41365125-F5931D13-708E-4D9A-BB36-51EC9BAC3C79Q45964404-EC0FB08F-6576-4BF8-8721-43CE76F6B568Q47355982-2A3E9773-DADE-4F5B-9297-A2A21E836A10Q47432725-2A1075CE-1001-40DA-888B-5112FC0D0057Q47736062-73128933-767D-4644-9501-03156B380E5CQ47912361-8F004DDA-E0E7-4068-AEDC-65DB77354A36Q48681416-32E5FD35-6BE7-48F0-B382-551681C6E8A6Q50435067-CB8DA4B3-5C3C-4840-9F3C-69091D543E59Q51232554-4D4F571F-8D16-4189-A9E1-62C815780D85Q54301320-FF6CD51D-CF8A-435D-913A-D24763FACB4DQ57325993-115D6413-95C6-44A0-8D9E-594682546874
P2860
Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@en
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@nl
type
label
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@en
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@nl
prefLabel
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@en
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@nl
P2093
P50
P1476
Mitotic checkpoints and chromo ...... strointestinal stromal tumors.
@en
P2093
Agnès Neuville
Alain Aurias
Audrey Kauffmann
Céline Brulard
Frédéric Chibon
Gaëlle Pérot
Isabelle Hostein
Jean-Michel Coindre
Pauline Lagarde
Valérie Dapremont
P304
P356
10.1158/1078-0432.CCR-11-1610
P407
P577
2011-12-13T00:00:00Z